On 28th February 2024, we at Focus Point celebrates a significant milestone as we embark on a new journey to revolutionize eye care in Malaysia.
This milestone marks the signing of Memorandum of Understanding between Focus Point, EyeMD Associates Sdn Bhd, and Airdoc Technology (HK) Limited. This collaboration signifies Focus Point’s commitment to leveraging cutting-edge technology to provide our customers with the best possible vision care solutions.
We are proud to form a strategic partnership with EyeMD and Airdoc to offer Airdoc's AI-powered Fundus Interpretation screening service within our retail outlets.
The MoU Signing Ceremony was represented by Dato' Liaw Choon Liang, CEO of Focus Point, Mr. Jerry Yang, Chief Representative of Airdoc, and Mr. Liew Jia Hao, representative of EyeMD.
Through Airdoc's AI technology, customers can gain valuable insights of their eye health and potential risks for over 35 chronic diseases, including diabetes, glaucoma, and hypertension, empowering early detection and preventive measures. This screening is conducted by Focus Point’s registered Optometrists.
